These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 21649973)
1. Beyond the coronary arteries: possible benefits of statin drugs. Part II: specific syndromes. Harv Mens Health Watch; 2011 May; 15(10):1-5. PubMed ID: 21649973 [No Abstract] [Full Text] [Related]
2. Beyond the coronary arteries: possible benefits of statin drugs. Part I: Meet the statins. Harv Mens Health Watch; 2011 Apr; 15(9):5-7. PubMed ID: 21560292 [No Abstract] [Full Text] [Related]
3. Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients? Steffens S; Mach F Nat Clin Pract Nephrol; 2006 Jul; 2(7):378-87. PubMed ID: 16932466 [TBL] [Abstract][Full Text] [Related]
4. Statins, cardiovascular disease, and drug safety. Gotto AM Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326 [TBL] [Abstract][Full Text] [Related]
5. Fixed dose combination therapy and CVD protection: "a need of the hour". Chopra HK Indian Heart J; 2009; 61(4):316-21. PubMed ID: 20635732 [No Abstract] [Full Text] [Related]
7. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. Yoshida S; Kamihata H; Nakamura S; Senoo T; Manabe K; Motohiro M; Sugiura T; Iwasaka T J Cardiol; 2009 Oct; 54(2):192-8. PubMed ID: 19782255 [TBL] [Abstract][Full Text] [Related]
8. Statins in women for primary prevention--is there evidence to back up their use?? Fenton A; Panay N Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236 [No Abstract] [Full Text] [Related]
12. Clinical review: impact of statin substitution policies on patient outcomes. Atar D; Carmena R; Clemmensen P; K-Laflamme A; Wassmann S; Lansberg P; Hobbs R Ann Med; 2009; 41(4):242-56. PubMed ID: 19191052 [TBL] [Abstract][Full Text] [Related]
13. [Statins available from chemist shops will positively affect health]. Thomas S Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1404. PubMed ID: 17668605 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention. Carrington MJ; Retegan C; Johnston CI; Jennings GL; Stewart S J Clin Nurs; 2009 Mar; 18(5):678-86. PubMed ID: 19077020 [TBL] [Abstract][Full Text] [Related]
16. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe? Seshasai SR; Ray KK Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188 [TBL] [Abstract][Full Text] [Related]
17. Statins in patients with chronic kidney disease: why, who and when? Gluba A; Rysz J; Banach M Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401 [TBL] [Abstract][Full Text] [Related]
18. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP; J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964 [TBL] [Abstract][Full Text] [Related]
19. Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story. Wierzbicki AS Int J Clin Pract; 2007 Jul; 61(7):1064-7. PubMed ID: 17577288 [No Abstract] [Full Text] [Related]
20. High dose statin therapy for all patients with coronary artery disease? Knobler H Isr Med Assoc J; 2005 Nov; 7(11):736-8. PubMed ID: 16308999 [No Abstract] [Full Text] [Related] [Next] [New Search]